KLDO (Kaleido Biosciences) Research & Development: $67.80 Mil (TTM As of Dec. 2021)


What is Kaleido Biosciences Research & Development?

Kaleido Biosciences KLDO Research & Development is $67.80 Mil as of Dec. 2021.

Research & Development is the aggregate amount of research and development expenses during the year. Kaleido Biosciences's Research & Development for the three months ended in Dec. 2021 was $15.57 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2021 was $67.80 Mil.

Kaleido Biosciences  (OTCPK:KLDO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Kaleido Biosciences Research & Development Related Terms

Kaleido Biosciences Research & Development Historical Data

* Premium members only.

The historical data trend for Kaleido Biosciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences Research & Development Chart

Kaleido Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Research & Development
Get a 7-Day Free Trial 20.99 42.06 64.23 55.97 67.80

Kaleido Biosciences Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.34 17.19 17.63 17.41 15.57

Kaleido Biosciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $67.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $67.80 Mil mean?
Kaleido Biosciences (KLDO) has a Research & Development of $67.80 Mil as of Dec. 2021. Research and development expense is the total cost for research and development activities. View historical data on Kaleido Biosciences and its competitors.
Is Kaleido Biosciences' Research & Development too high?
Kaleido Biosciences' current Research & Development is $67.80 Mil.
How does Kaleido Biosciences' Research & Development compare to NPTX and GSTC?
Kaleido Biosciences' Research & Development of $67.80 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Kaleido Biosciences and its competitors. Kaleido Biosciences's current Research & Development is $67.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaleido Biosciences stock overvalued right now?
Kaleido Biosciences (KLDO) has a current Research & Development of $67.80 Mil. The current Research & Development is $67.80 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Kaleido Biosciences (KLDO), the current Research & Development is $67.80 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kaleido Biosciences Business Description

Address 65 Hayden Avenue, Lexington, MA, USA, 02421
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.